Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-22

Clinical Trial Update: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

View source ↗

Summary

This Stanford University clinical trial aims to identify prognostic factors in Mycosis fungoides and Sézary syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Mycosis Fungoides, Non-Hodgkin's Lymphoma | Status: RECRUITING